Physician profile
Parvine Rustamova
NPI 1730506882
$4,252.82
in general payments reported to CMS, 2019-2025
16 companies · $1,131 in 2025
The $1,131 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,107 · 2021: $388 · 2022: $487 · 2023: $274 · 2024: $865 · 2025: $1,131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,270.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,456.12 | 2019-2025 | Aveir, Gallant |
| Abiomed | $514.77 | 2019-2024 | Impella |
| Shockwave Medical, INC | $419.87 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Chiesi USA, INC. | $237.17 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $226.05 | 2019-2025 | Camzyos |
| Cardiovascular Systems INC. | $175.18 | 2022 | |
| Boston Scientific Corporation | $156.94 | 2025 | Enroute Transcarotid Neuroprotection System |
| Penumbra, INC. | $147.29 | 2025 | Indigo System |
| Scpharmaceuticals INC. | $146.19 | 2023 | |
| Sanofi-Aventis U.S. LLC | $124.90 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $119.02 | 2021 | |
| Amarin Pharma, INC. | $114.74 | 2019 | |
| Medtronic Vascular, INC. | $109.01 | 2019 | |
| Abbvie INC. | $105.63 | 2019 | |
| Pfizer INC. | $102.05 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $97.89 | 2024 | Symplicity G3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parvine Rustamova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.